Participating Faculty: Use of Opioid Analgesics in Managed Care Practice: Challenges, Controversies, REMS, and Optimizing Patient Management [CME/CPE]

Faculty

This supplement to The American Journal of Managed Care describes patients with or at risk for opioid use disorder to facilitate early intervention and treatment, outline the clinical and economic impact of opioid misuse and the implementation of a REMS program into managed care practice, and distinguish between general and productspecific drug information surrounding different extended- release and long-acting opioid analgesics, including updated safety labeling.

Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP

Adjunct Associate Professor

Western New England University

College of Pharmacy

Springfield, Massachusetts

Adjunct Assistant Professor of Pharmacy Practice

University of Connecticut School of Pharmacy

Storrs, Connecticut

Clinical Pharmacy Specialist in Pain Management

Director

PGY2 Pharmacy Pain & Palliative Care Residency

Stratton VA Medical Center

Albany, New York*

Bill McCarberg, MD, FABPM

Physician

Neighborhood Healthcare

Medical Director

Elizabeth Hospice

Escondido, California

Adjunct Assistant Clinical Professor

University of California San Diego

President

American Academy of Pain Medicine

James B. Ray, PharmD, CPE

James A. Otterbeck OnePoint Patient Care

Clinical Associate Professor in Hospice and Palliative Care

Department of Pharmacy Practice and Science

University of Iowa College of Pharmacy

Iowa City, Iowa

Editorial Support

Jill E. Allen, PharmD, BCPS

Drug Information Consultant

Pin Oak Associates

Salt Lake City, Utah

Priya Karkhanis, MS

Scientific Consultant

Hillsborough, New Jersey

Christine Sokoloski, MS

Scientific Consultant

Hillsborough, New Jersey

*Statements are the sole opinion of Dr. Fudin and do not reflect the opinion of employers, employee affiliates.

Faculty Disclosures

Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, reports the following relevant commercial financial relationships in the past 12 months:

Consultant: AstraZeneca, Depomed, Kaléo Pharma, Millennium Health LLC, Zogenix

Speakers’ bureaus: AstraZeneca, Kaléo Pharma, Millennium Health LLC

Lecture fees: PainWeek and Pain Weekend

Bill McCarberg, MD, FABPM, reports the following relevant commercial financial relationships or affiliations in the past 12 months:

Consultant: AstraZeneca, Collegium, Depomed, Inspirion, Iroko, Janssen, Kaléo, Mallinckrodt, Millennium, Pfizer, Salix, Takeda, Zogenix

Board membership: American Academy of Pain Medicine, American Board of Pain Medicine

Stockholder: Biospecifics Technologies, Galena, Johnson & Johnson, Nektar Therapeutics, Protein Design Labs

James B. Ray, PharmD, CPE, reports the following relevant commercial financial relationships or affiliations in the past 12 months:

Consultant and honoraria: AstraZeneca, Mallinckrodt Pharmaceuticals

Lecture fees: PainWeek and Pain Weekend

Meeting/conference attendance: PainWeek

Stockholder: Alchemy Consulting, PC

Editorial Support Disclosures

Jill E. Allen, PharmD, BCPS; Priya Karkhanis, MS; and Christine Sokoloski, MS, have no relevant commercial financial relationships or affiliations to disclose.

The American Journal of Managed Care

Publishing Staff—Jeff D. Prescott, PharmD, RPh; Ida Delmendo; and Cindy Spielvogel have no relevant financial relationships with commercial interests to disclose.

University of Cincinnati

Planning Staff—Susan P. Tyler, MEd, CMP, CCMEP, Director, University of Cincinnati, has nothing to disclose.

CME Physician Reviewer—Rick Ricer, MD, University of Cincinnati, has nothing to disclose.

Pharmacy Times Office of Continuing Professional Education

Planning staff—David Heckard; Maryjo Dixon, RPh; Donna Fausak; and Nathalie Harden have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy

According to the disclosure policy of the University of Cincinnati, all persons who are in a position to control content are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of the University of Cincinnati and Pharmacy Times Office of Continuing Professional Education to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Disclosure of Unapproved/Off-Label Use

The contents of this activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Participants should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

The information provided in this CE/CME activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care, Pharmacy Times Office of Continuing Professional Education, and the University of Cincinnati, or any of the companies that provided commercial support for this CE/CME activity.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, the editorial staff, or any member of the editorial advisory board. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.

Download PDF: Participating Faculty: Use of Opioid Analgesics in Managed Care Practice: Challenges, Controversies, REMS, and Optimizing Patient Management [CME/CPE]